Search & Filter
Investor Categories
Earnings & Results Shareholder Returns Management & Governance Business Strategy ESG & Sustainability Regulatory Disclosure Capital Structure Earnings Flash Other
Clear Filters

IR Information List

1521 items
Code Company Type Importance Title Date
4417 Global Security Experts Inc. M&A Notice of Capital and Business Alliance with Keyware Solutions Co., Ltd. Sep 30, 2026 NEW
3799 Keyware Solutions Inc. M&A Notice of Capital and Business Alliance with Global Security Expert Inc. Sep 30, 2026 NEW
3140 BRUNO,Inc. Strategy BRUNO,Inc. Matters Concerning Business Plan and Growth Potential Sep 30, 2026 NEW
6597 HPC SYSTEMS Inc. Strategy Disclosure of Business Model and Vision2027 Medium-Term Management Plan Sep 30, 2026 NEW
5254 Arent Inc. Strategy Notice of Acquisition of All Shares of Asakura Soft, Kensetsu Dot Web and Lets by Arent Inc. Sep 30, 2026 NEW
4461 DKS Co. Ltd. Strategy Notice Regarding Capital Expenditure for Low-Dielectric Resin Manufacturing Facilities (Details) Sep 30, 2026 NEW
9672 Tokyotokeiba Co.,Ltd. Strategy Notice Regarding Acquisition of Fixed Assets for Redevelopment of Oi Racecourse Sep 30, 2026 NEW
7375 REFINVERSE Group, Inc. Strategy REFINVERSE Group Business Plan and Growth Potential Materials Sep 30, 2026 NEW
7320 Solvvy Inc. Strategy Matters Concerning Solvvy Group’s Business Plan and Growth Potential Sep 30, 2026 NEW
6182 MetaReal Corporation Strategy Announcement on Progress of Disclosed Matters: Notice of Major New Feature Development at Consolidated Subsidiary — Achieving “Fully Automated Translation”, Completion of “Translation AI That Requires No Human Post-Editing” Sep 30, 2026 NEW
5603 Kogi Corporation Strategy Notice on Formulation of Long-term Vision “KOGI S&G Vision” Sep 30, 2026 NEW
4840 TriIs Incorporated M&A Notice of Basic Agreement on the Joint Venture of LIMNO Co., Ltd. with Icom, Inc. Sep 30, 2026 NEW
4586 MedRx Co., Ltd M&A Regarding U.S. Sales Partnership with Terrain for “Bondlido” and Launch Timing Sep 30, 2026 NEW
4577 Daito Pharmaceutical Co.,Ltd. M&A Daito Pharmaceutical Co.,Ltd. to Establish Jointly Funded Company for Succession of Kyorin Pharmaceutical’s Generic Drug Business and Conclude Share Transfer Agreement Sep 30, 2026 NEW
4538 Fuso Pharmaceutical Industries,Ltd. Strategy Notice of Execution of Design and Construction Contract for Okayama No.2 Plant Sep 30, 2026 NEW
4442 Valtes Holdings Co.,Ltd. M&A Notice of Completion of Share Acquisition (Subsidiarization) Sep 30, 2026 NEW
3803 Image Information Inc. Strategy Medium-Term Management Plan 2029 “Project Image” Executive Summary Sep 30, 2026 NEW
3300 AMBITION DX HOLDINGS Co., Ltd. Strategy Presentation Materials on Business Plan and Growth Potential Sep 30, 2026 NEW
2269 Meiji Holdings Co., Ltd. M&A Conclusion of Joint Venture and Share Transfer Agreements for Succession of Kyorin Pharmaceutical’s Generic Drug Business by Meiji Holdings Co., Ltd. and Three Other Companies Sep 30, 2026 NEW
7371 Zenken Corporation Strategy Zenken Corporation: Matters Concerning Business Plan and Growth Potential Sep 30, 2026 NEW